Acrivastine and pseudoephedrine and Dolutegravir 25 mg and 50 mg
Determining the interaction of Acrivastine and pseudoephedrine and Dolutegravir 25 mg and 50 mg and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acrivastine / pseudoephedrine
Brand name: Semprex-D
Synonyms: Acrivastine and Pseudoephedrine
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Dolutegravir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acrivastine and pseudoephedrine-Dolutegravir and lamivudine
- Acrivastine and pseudoephedrine-Dolutegravir and rilpivirine
- Acrivastine and pseudoephedrine-Dolutegravir Sodium
- Acrivastine and pseudoephedrine-Dolutegravir Sodium And Lamivudine
- Acrivastine and pseudoephedrine-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Acrivastine and pseudoephedrine-Dom-Etoposide
- Dolutegravir 25 mg and 50 mg-Actamin
- Dolutegravir 25 mg and 50 mg-Actamin Maximum Strength
- Dolutegravir 25 mg and 50 mg-Actemra
- Dolutegravir 25 mg and 50 mg-Actemra (Tocilizumab (Intravenous))
- Dolutegravir 25 mg and 50 mg-Actemra (Tocilizumab Auto-Injectors)
- Dolutegravir 25 mg and 50 mg-Actemra (Tocilizumab Prefilled Syringes)